FDA, EU diverge on AstraZeneca COVID-19 vaccine
FDA, EU diverge on AstraZeneca COVID-19 vaccine

The Food and Drug Administration widened its probe into a serious illness linked to halted clinical trials for AstraZeneca's potential COVID-19 vaccine, sources told Reuters, while in Europe the vaccine approval process has been put on the fast track.

Conway G.

Gittens reports.